Labcorp Total Assets 2010-2024 | LH

Labcorp total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Labcorp total assets for the quarter ending March 31, 2024 were $16.725B, a 17.02% decline year-over-year.
  • Labcorp total assets for 2023 were $16.725B, a 17.02% decline from 2022.
  • Labcorp total assets for 2022 were $20.155B, a 1.13% decline from 2021.
  • Labcorp total assets for 2021 were $20.385B, a 1.56% increase from 2020.
Labcorp Annual Total Assets
(Millions of US $)
2023 $16,725
2022 $20,155
2021 $20,385
2020 $20,072
2019 $18,046
2018 $16,185
2017 $16,673
2016 $14,247
2015 $14,105
2014 $7,302
2013 $6,966
2012 $6,795
2011 $6,112
2010 $6,188
2009 $4,838
Labcorp Quarterly Total Assets
(Millions of US $)
2023-12-31 $16,725
2023-09-30 $16,886
2023-06-30 $17,719
2023-03-31 $20,200
2022-12-31 $20,155
2022-09-30 $19,826
2022-06-30 $20,403
2022-03-31 $20,728
2021-12-31 $20,385
2021-09-30 $20,867
2021-06-30 $20,417
2021-03-31 $20,417
2020-12-31 $20,072
2020-09-30 $18,740
2020-06-30 $17,849
2020-03-31 $17,298
2019-12-31 $18,046
2019-09-30 $17,848
2019-06-30 $17,744
2019-03-31 $16,971
2018-12-31 $16,185
2018-09-30 $16,661
2018-06-30 $16,505
2018-03-31 $16,832
2017-12-31 $16,673
2017-09-30 $16,692
2017-06-30 $14,903
2017-03-31 $14,428
2016-12-31 $14,247
2016-09-30 $14,483
2016-06-30 $14,199
2016-03-31 $14,410
2015-12-31 $14,105
2015-09-30 $14,422
2015-06-30 $14,465
2015-03-31 $14,151
2014-12-31 $7,302
2014-09-30 $7,232
2014-06-30 $7,145
2014-03-31 $6,992
2013-12-31 $6,966
2013-09-30 $6,687
2013-06-30 $6,592
2013-03-31 $6,569
2012-12-31 $6,795
2012-09-30 $6,814
2012-06-30 $6,098
2012-03-31 $6,131
2011-12-31 $6,112
2011-09-30 $6,053
2011-06-30 $6,168
2011-03-31 $6,202
2010-12-31 $6,188
2010-09-30 $5,048
2010-06-30 $4,958
2010-03-31 $4,934
2009-12-31 $4,838
2009-09-30 $4,830
2009-06-30 $4,713
2009-03-31 $4,828
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.691B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.394B 19.11
Becton Dickinson (BDX) United States $66.895B 19.43
West Pharmaceutical Services (WST) United States $26.385B 47.05
Cardinal Health (CAH) United States $25.104B 15.09
Align Technology (ALGN) United States $23.254B 44.92
Cooper (COO) United States $17.657B 26.72
Henry Schein (HSIC) United States $9.396B 16.25
DENTSPLY SIRONA (XRAY) United States $6.339B 16.70
Merit Medical Systems (MMSI) United States $4.284B 24.51
Patterson (PDCO) United States $2.309B 11.06
STAAR Surgical (STAA) United States $2.307B 72.25
CONMED (CNMD) United States $2.025B 18.37
Atrion (ATRI) United States $0.695B 35.81
Lifevantage (LFVN) United States $0.080B 12.89
Pro-Dex (PDEX) United States $0.066B 24.91
Biolase (BIOL) United States $0.005B 0.00